Literature DB >> 2779241

Alcoholism and depressive symptomatology among convicted DWI men and women.

M Windle1, B A Miller.   

Abstract

Interrelationships between DSM-III-based alcoholism diagnostic groups and depressive symptomatology were assessed for a sample of 461 convicted DWI offenders. The highest rate of depressive symptomatology was reported by persons diagnosed as alcohol dependent, and such findings were robust across male and female offenders. However, a significant interaction effect was found in which alcohol-dependent women reported higher levels of depressive symptomatology than alcohol-dependent men. With the exception that men reported significantly more previous DWI arrests than women, few differences were found between the gender groups with respect to a range of demographic variables, alcohol use and alcohol-related problems.

Entities:  

Mesh:

Year:  1989        PMID: 2779241     DOI: 10.15288/jsa.1989.50.406

Source DB:  PubMed          Journal:  J Stud Alcohol        ISSN: 0096-882X


  4 in total

1.  Performance and quality of life outcome in patients completing concomitant chemoradiotherapy protocols for head and neck cancer.

Authors:  M A List; P Mumby; D Haraf; A Siston; R Mick; E MacCracken; E Vokes
Journal:  Qual Life Res       Date:  1997-04       Impact factor: 4.147

2.  Life-time drinking course of driving-while-impaired offenders.

Authors:  Sandra C Lapham; Betty J Skipper; Marcia Russell
Journal:  Addiction       Date:  2012-08-20       Impact factor: 6.526

3.  High Risk of Alcohol-Impaired Driving in Adults With Comorbid Alcohol and Substance Use Disorders in the U.S. Population.

Authors:  Walter Roberts; Kelly E Moore; Brian P Pittman; Mark T Fillmore; Sherry A McKee
Journal:  J Stud Alcohol Drugs       Date:  2019-01       Impact factor: 2.582

4.  Meta-analysis of depression and substance use among individuals with alcohol use disorders.

Authors:  Kenneth R Conner; Martin Pinquart; Stephanie A Gamble
Journal:  J Subst Abuse Treat       Date:  2009-01-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.